SKU-level data that helps life sciences and medical device organizations address RWD/RWE needs to support research, solution development and regulatory requirements.
An equity-centered, design-thinking approach is helping health systems, life sciences, community and patient organizations co-design solutions to reduce health disparities.
In a recent PINC AI™ webinar, Jim Sianis speaks about the types of health data used for research and patient care.
Artificial intelligence and clinical natural language processing is unlocking the unstructured data within clinician notes and pathology reports to support smarter healthcare.
The One-Stop Clinic™ experience is lessening diagnosis time from a national average of 26 days to less than 48 hours.
PINC AI™ Applied Sciences is committed to advancing health equity through real-world, data-driven research and solutions co-designed with health systems and life sciences partners.
PINC AI™ Applied Sciences, AstraZeneca and Clinithink win BWB Award for innovative use of technology-enabled healthcare solutions in Digital Medicine.
The PHD provides a deeper set of insights into diseases allowing researchers to run stronger analyses and help to predict future trends and outbreaks.
To improve healthcare outcomes, we must focus our efforts on reducing harm, driving clinical quality improvements, advancing health equity and reducing disparities for all.
PINC AI™ is narrowing the gaps in maternal and infant care through standardized and timely data.
One database offers visibility into the maternal and infant relationship to support clinical research and medical solution development that can impact perinatal health.
Innovation in data analytics and real-world evidence is helping life sciences companies expedite treatment development and uncover new uses for existing treatments.
PAS continues to spearhead research in understanding outcomes of COVID-19 and its impact on pregnant women, increased risk of myocarditis and healthcare resource utilization.
Investing in a Decentralized Clinical Trial strategy can help improve life sciences companies' resilience and research efforts and deliver strategic returns.
Learn how to use PINC AI™ Healthcare Data to gain in-depth, patient-level, longitudinal real-world data to save money, time and support efficient healthcare decisions.
Here are three ways life science companies can utilize real-world data and evidence derived from charge master data to provide value and improve outcomes.
Three ways to effectively use real-world-data and real-world evidence to conduct clinical studies, improve drug, device, and diagnostic discovery, and gain regulatory approval.
Understand the new CMS Maternal Morbidity Structural Measure and learn how Premier can help your hospital or health systems answer ‘yes’ to this measure.
Life sciences companies need to invest in RWD/RWE as payers, regulatory bodies, and health systems demand proof that a medical solution delivers real value.
Many diseases are caused by alterations in our genes. By identifying these alterations through genomics, people can gain valuable information about their risk.
A main objective for any life sciences company is to demonstrate the value of their products in improving the lives of patients and ensure...
How can providers educate patients about their options, overcome patient vaccine hesitancy, reduce racial and ethnic disparities and ensure supply to increase flu vaccination rates?
How PINC AI™ Applied Sciences, GE and St. Luke’s University Health Network Came Together to Adapt a One-Stop Breast Clinic Model for the United States...
The life sciences industry is fueled by research and innovation, with a focus on developing, teaching, testing and researching care delivery practices and real-world interventions...
PIRC aims to assist partners with innovation and to optimize healthcare and its delivery through research and collaborative efforts.
This collaborative aims to investigate outcomes of mothers and babies individually and together, identify social determinants of health and uncover strategies to reduce racial, ethnic...
There is an urgent need to understand the clinical and economic consequences associated with AKI in hospitalized patients with COVID-19 to better inform treatment decisions...
Persistent severe AKI in hospitalized patients can cause adverse outcomes, clinicians are working to identify risks and provide intervention to improve outcomes and reduce costs.
The SARS-Cov-2 delta variant has filled U.S. hospitals to capacity reinforcing the need for data to better understand disease severity and support evidence-based treatment decisions...
Premier Applied Sciences and Meitheal Pharmaceuticals collaborate to study anticoagulant use in COVID-19 patients.
The healthcare technology market today is flooded with ideas but creating meaningful and sustainable change is complex.
Get a sneak peek at Premier's tools to assess, diagnose and care for patients who may be appropriate candidates for new AD treatments.
Natural language processing technology is a promising gamechanger.
Premier Applied Sciences, the research and analytics division of Premier, is putting game-changing NLP technology into the hands of health systems and life sciences companies.
The Premier Healthcare Database has become a frontrunner in COVID-19 research, used by the CDC, the NIH and leading academic institutions.
At Premier, our members have partnered with us to find truly innovative solutions to the biggest problems facing healthcare and our nation during the pandemic.
Every organization is thirsting for data, trajectories and guidance in real time. Leveraging a proven collaborative model is key.
Premier's Leigh Anderson and Denise Juliano discuss the steps life science companies are taking to shorten the time required to bring solutions to market.
With the increasing number of Americans living with Alzheimer’s comes an increased need for care.
Providers should be thinking through how to determine which early treatments are most effective, capture the results of clinical trials and lead through innovation.
From all of us at Premier, thank you to all the frontline healthcare workers. Keep up the fight. Premier is in your corner.
Approximately 97% of hospitals have implemented at least one conservation protocol for PPE, per our latest survey.
Premier data indicates that demand for chloroquine and hydroxychloroquine spiked dramatically between March 1-17.
Check out six guidelines we're recommending in our daily conversations with healthcare providers, governmental agencies and industry stakeholders.
Premier presented insights and data on supplies that are on allocation and in shortage, and recommendations to protect our supply chain.
Its newfound popularity brings hope of a brighter future in successfully treating a variety of diseases, including multiple forms of cancer.
Looking at the HIV care model, there were three notable components working together to achieve successful population health management.
As your leading research and analytics partner, PINC AI™ Applied Sciences can help your organization improve the overall quality, safety and cost-effectiveness of care.